Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for prevention of postoperative cognitive dysfunction in elderly patients
ChiCTR2400090414Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ketamine in post-operative cognitive decline (POCD) and Alzheimer's disease (AD) (3 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoint: Mini-Mental State Examination (MMSE) at 72 hours. Started Sep 2024; status: recruiting.
02
Drugs
ketamine
03
Conditions
post-operative cognitive decline (POCD)Alzheimer's disease (AD)
Beyond the preview
Go deeper on ChiCTR2400090414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090414.